血小板减少-话题@MedSci

#血小板减少#

161篇内容 | 5057人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1302878, encodeId=883213028e838, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=王琳教授—血小板减少真真假假，1小时教您轻松识别, objectType=article, longId=294812, objectId=2f7d2948128a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f7d2948128a, replyNumber=0, likeNumber=88, createdTime=2022-01-29, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f7d2948128a, moduleTitle=王琳教授—血小板减少真真假假，1小时教您轻松识别, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f7d2948128a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302877, encodeId=ef5b13028e76f, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=EDTA-K2和枸橼酸钠同时依赖的假性血小板减少，你见过么？, objectType=article, longId=294637, objectId=cebb29463ee5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cebb29463ee5, replyNumber=0, likeNumber=105, createdTime=2022-01-26, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cebb29463ee5, moduleTitle=EDTA-K2和枸橼酸钠同时依赖的假性血小板减少，你见过么？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cebb29463ee5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302876, encodeId=dcb013028e65e, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Neurol Clin Pract：自发性肝素诱导血小板减少症致急性缺血性卒中1例, objectType=article, longId=294317, objectId=9b2929431e31, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b2929431e31, replyNumber=0, likeNumber=101, createdTime=2022-01-21, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b2929431e31, moduleTitle=Neurol Clin Pract：自发性肝素诱导血小板减少症致急性缺血性卒中1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b2929431e31)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302875, encodeId=bcfe13028e52c, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Acta Haematol：成功治疗 26 岁女性患者疫苗引起的免疫性血栓性血小板减少症, objectType=article, longId=293608, objectId=7f392936087d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f392936087d, replyNumber=0, likeNumber=84, createdTime=2022-01-09, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f392936087d, moduleTitle=Acta Haematol：成功治疗 26 岁女性患者疫苗引起的免疫性血栓性血小板减少症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f392936087d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302874, encodeId=a77613028e431, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Lancet Haematol：全反式视黄酸加大剂量地塞米松可作为新诊断免疫性血小板减少症患者的一线治疗, objectType=article, longId=293423, objectId=5f6429342357, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f6429342357, replyNumber=0, likeNumber=99, createdTime=2022-01-06, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f6429342357, moduleTitle=Lancet Haematol：全反式视黄酸加大剂量地塞米松可作为新诊断免疫性血小板减少症患者的一线治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f6429342357)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302873, encodeId=720a13028e3d5, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Ann Hematol：在卡帕珠单抗前时代获得性血栓性血小板减少性紫癜的死亡率, objectType=article, longId=293184, objectId=ac6f29318456, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac6f29318456, replyNumber=0, likeNumber=79, createdTime=2022-01-01, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac6f29318456, moduleTitle=Ann Hematol：在卡帕珠单抗前时代获得性血栓性血小板减少性紫癜的死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac6f29318456)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302872, encodeId=f03513028e228, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=AJH：艾曲波帕治疗单倍体相同外周血干细胞移植后持续性血小板减少症患者, objectType=article, longId=220708, objectId=5e53220e080d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e53220e080d, replyNumber=0, likeNumber=100, createdTime=2021-11-22, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e53220e080d, moduleTitle=AJH：艾曲波帕治疗单倍体相同外周血干细胞移植后持续性血小板减少症患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e53220e080d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302871, encodeId=e8e113028e166, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Blood：黄晓军团队发现全反式维甲酸+低剂量利妥昔单抗治疗难治/复发性免疫性血小板减少症, objectType=article, longId=220605, objectId=a14b22060538, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a14b22060538, replyNumber=0, likeNumber=94, createdTime=2021-11-20, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a14b22060538, moduleTitle=Blood：黄晓军团队发现全反式维甲酸+低剂量利妥昔单抗治疗难治/复发性免疫性血小板减少症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a14b22060538)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302870, encodeId=208c13028e0ea, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=BJH：高龄患者的原发性免疫性血小板减少症表现和治疗的特殊性, objectType=article, longId=220422, objectId=c119220422a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c119220422a7, replyNumber=0, likeNumber=85, createdTime=2021-11-17, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c119220422a7, moduleTitle=BJH：高龄患者的原发性免疫性血小板减少症表现和治疗的特殊性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c119220422a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302869, encodeId=dcf71302869b1, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=AJH：冻干血小板是血液系统恶性肿瘤出血性血小板减少症患者的一种有希望的替代方法, objectType=article, longId=220255, objectId=220222025520, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=220222025520, replyNumber=0, likeNumber=84, createdTime=2021-11-14, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=220222025520, moduleTitle=AJH：冻干血小板是血液系统恶性肿瘤出血性血小板减少症患者的一种有希望的替代方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=220222025520)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302868, encodeId=2f6b13028684c, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Blood Cells Mol Dis：艾曲波帕作为原发性免疫性血小板减少症患者二线治疗的有效性和安全性, objectType=article, longId=219573, objectId=1bc72195e3c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bc72195e3c8, replyNumber=0, likeNumber=84, createdTime=2021-11-02, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bc72195e3c8, moduleTitle=Blood Cells Mol Dis：艾曲波帕作为原发性免疫性血小板减少症患者二线治疗的有效性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bc72195e3c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302867, encodeId=2a21130286e8b, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=NEJM：疫苗诱导免疫性血小板减少症和血栓形成的临床特征, objectType=article, longId=219468, objectId=756121946838, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=756121946838, replyNumber=0, likeNumber=99, createdTime=2021-10-30, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=756121946838, moduleTitle=NEJM：疫苗诱导免疫性血小板减少症和血栓形成的临床特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=756121946838)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302866, encodeId=8a5e130286666, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Lancet Haemat：全反式维甲酸+大剂量地塞米松或可成为原发性免疫性血小板减少症的新一线疗法！, objectType=article, longId=218057, objectId=abc921805e25, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abc921805e25, replyNumber=0, likeNumber=73, createdTime=2021-10-04, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abc921805e25, moduleTitle=Lancet Haemat：全反式维甲酸+大剂量地塞米松或可成为原发性免疫性血小板减少症的新一线疗法！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abc921805e25)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302865, encodeId=76781302865f4, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=NEJM：吗替麦考酚酯可作为免疫性血小板减少症患者的一线治疗, objectType=article, longId=216619, objectId=6567216619d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6567216619d2, replyNumber=0, likeNumber=91, createdTime=2021-09-04, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6567216619d2, moduleTitle=NEJM：吗替麦考酚酯可作为免疫性血小板减少症患者的一线治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6567216619d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302864, encodeId=189713028641d, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=JAMA: 阿斯利康、杨森/强生COVID-19疫苗引起脑静脉窦血栓形成和血小板减少又添新佐证, objectType=article, longId=215031, objectId=ced7215031a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ced7215031a6, replyNumber=0, likeNumber=80, createdTime=2021-07-31, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ced7215031a6, moduleTitle=JAMA: 阿斯利康、杨森/强生COVID-19疫苗引起脑静脉窦血栓形成和血小板减少又添新佐证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ced7215031a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302863, encodeId=5bdc13028634a, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=JNNP：ChAdOx1-nCoV-19疫苗诱导的以缺血性中风为表现的免疫性血栓性血小板减少症 , objectType=article, longId=212889, objectId=4f182128894d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f182128894d, replyNumber=0, likeNumber=90, createdTime=2021-06-20, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f182128894d, moduleTitle=JNNP：ChAdOx1-nCoV-19疫苗诱导的以缺血性中风为表现的免疫性血栓性血小板减少症 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f182128894d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302862, encodeId=837a130286207, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=新英格兰：COVID-19疫苗诱导的血小板减少症的免疫球蛋白辅助疗法, objectType=article, longId=212672, objectId=62e72126e234, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62e72126e234, replyNumber=0, likeNumber=76, createdTime=2021-06-15, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62e72126e234, moduleTitle=新英格兰：COVID-19疫苗诱导的血小板减少症的免疫球蛋白辅助疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62e72126e234)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302861, encodeId=a9751302861be, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=NEJM：ChAdOx1 nCov-19接种后血栓性血小板减少事件研究, objectType=article, longId=212261, objectId=3d07212261b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d07212261b2, replyNumber=0, likeNumber=79, createdTime=2021-06-05, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d07212261b2, moduleTitle=NEJM：ChAdOx1 nCov-19接种后血栓性血小板减少事件研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d07212261b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302860, encodeId=8c6e130286090, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=JNNP：ChAdOx1-nCoV-19疫苗诱导的以缺血性中风为表现特征免疫性血栓性血小板减少症, objectType=article, longId=211954, objectId=788621195419, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=788621195419, replyNumber=0, likeNumber=74, createdTime=2021-05-29, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=788621195419, moduleTitle=JNNP：ChAdOx1-nCoV-19疫苗诱导的以缺血性中风为表现特征免疫性血栓性血小板减少症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=788621195419)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302859, encodeId=de60130285925, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=BMJ：丹麦和挪威的牛津-阿斯利康ChAdOx1-S疫苗接种后的动脉事件、静脉血栓栓塞、血小板减少和出血, objectType=article, longId=210915, objectId=00fa210915f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00fa210915f2, replyNumber=0, likeNumber=79, createdTime=2021-05-08, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00fa210915f2, moduleTitle=BMJ：丹麦和挪威的牛津-阿斯利康ChAdOx1-S疫苗接种后的动脉事件、静脉血栓栓塞、血小板减少和出血, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00fa210915f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

血小板减少

2020-05-29

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

王琳教授—血小板减少真真假假，1小时教您轻松识别

2022-01-29

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

EDTA-K2和枸橼酸钠同时依赖的假性血小板减少，你见过么？

2022-01-26

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Neurol Clin Pract：自发性肝素诱导血小板减少症致急性缺血性卒中1例

2022-01-21

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Acta Haematol：成功治疗 26 岁女性患者疫苗引起的免疫性血栓性血小板减少症

2022-01-09

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Lancet Haematol：全反式视黄酸加大剂量地塞米松可作为新诊断免疫性血小板减少症患者的一线治疗

2022-01-06

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Ann Hematol：在卡帕珠单抗前时代获得性血栓性血小板减少性紫癜的死亡率

2022-01-01

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

AJH：艾曲波帕治疗单倍体相同外周血干细胞移植后持续性血小板减少症患者

2021-11-22

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Blood：黄晓军团队发现全反式维甲酸+低剂量利妥昔单抗治疗难治/复发性免疫性血小板减少症

2021-11-20

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

BJH：高龄患者的原发性免疫性血小板减少症表现和治疗的特殊性

2021-11-17

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

AJH：冻干血小板是血液系统恶性肿瘤出血性血小板减少症患者的一种有希望的替代方法

2021-11-14

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Blood Cells Mol Dis：艾曲波帕作为原发性免疫性血小板减少症患者二线治疗的有效性和安全性

2021-11-02

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

NEJM：疫苗诱导免疫性血小板减少症和血栓形成的临床特征

2021-10-30

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Lancet Haemat：全反式维甲酸+大剂量地塞米松或可成为原发性免疫性血小板减少症的新一线疗法！

2021-10-04

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

NEJM：吗替麦考酚酯可作为免疫性血小板减少症患者的一线治疗

2021-09-04

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

JAMA: 阿斯利康、杨森/强生COVID-19疫苗引起脑静脉窦血栓形成和血小板减少又添新佐证

2021-07-31

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

JNNP：ChAdOx1-nCoV-19疫苗诱导的以缺血性中风为表现的免疫性血栓性血小板减少症

2021-06-20

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

新英格兰：COVID-19疫苗诱导的血小板减少症的免疫球蛋白辅助疗法

2021-06-15

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

NEJM：ChAdOx1 nCov-19接种后血栓性血小板减少事件研究

2021-06-05

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

JNNP：ChAdOx1-nCoV-19疫苗诱导的以缺血性中风为表现特征免疫性血栓性血小板减少症

2021-05-29

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

BMJ：丹麦和挪威的牛津-阿斯利康ChAdOx1-S疫苗接种后的动脉事件、静脉血栓栓塞、血小板减少和出血

2021-05-08

科室
- - 订阅+
  - 更多科室
工具
服务